NCT01017029View on ClinicalTrials.gov

Everolimus in de Novo Heart Transplant Recipients

PHASE4CompletedINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Cardiac Transplantation
Interventions
DRUG

Everolimus

DRUG

Mycophenolate mofetil + Everolimus

Trial Locations (12)

10126

Novartis Investigative Site, Torino

20162

Novartis Investigative Site, Milan

27100

Novartis Investigative Site, Pavia

33100

Novartis Investigative Site, Udine

35128

Novartis Investigative Site, Padua

37126

Novartis Investigative Site, Verona

40138

Novartis Investigative Site, Bologna

53100

Novartis Investigative Site, Siena

70124

Novartis Investigative Site, Bari

80131

Novartis Investigative Site, Napoli

09134

Novartis Investigative Site, Cagliari

00152

Novartis Investigative Site, Roma

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY